1
|
Dionne U, Chartier FJM, López de Los Santos Y, Lavoie N, Bernard DN, Banerjee SL, Otis F, Jacquet K, Tremblay MG, Jain M, Bourassa S, Gish GD, Gagné JP, Poirier GG, Laprise P, Voyer N, Landry CR, Doucet N, Bisson N. Direct Phosphorylation of SRC Homology 3 Domains by Tyrosine Kinase Receptors Disassembles Ligand-Induced Signaling Networks. Mol Cell 2018; 70:995-1007.e11. [PMID: 29910111 PMCID: PMC6014926 DOI: 10.1016/j.molcel.2018.05.013] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2017] [Revised: 03/20/2018] [Accepted: 05/10/2018] [Indexed: 11/23/2022]
Abstract
Phosphotyrosine (pTyr) signaling has evolved into a key cell-to-cell communication system. Activated receptor tyrosine kinases (RTKs) initiate several pTyr-dependent signaling networks by creating the docking sites required for the assembly of protein complexes. However, the mechanisms leading to network disassembly and its consequence on signal transduction remain essentially unknown. We show that activated RTKs terminate downstream signaling via the direct phosphorylation of an evolutionarily conserved Tyr present in most SRC homology (SH) 3 domains, which are often part of key hub proteins for RTK-dependent signaling. We demonstrate that the direct EPHA4 RTK phosphorylation of adaptor protein NCK SH3s at these sites results in the collapse of signaling networks and abrogates their function. We also reveal that this negative regulation mechanism is shared by other RTKs. Our findings uncover a conserved mechanism through which RTKs rapidly and reversibly terminate downstream signaling while remaining in a catalytically active state on the plasma membrane.
Collapse
Affiliation(s)
- Ugo Dionne
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada
| | - François J M Chartier
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada
| | - Yossef López de Los Santos
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, QC, Canada
| | - Noémie Lavoie
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada
| | - David N Bernard
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, QC, Canada
| | - Sara L Banerjee
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada
| | - François Otis
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; Département de Chimie, Université Laval, Québec, QC, Canada
| | - Kévin Jacquet
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada
| | - Michel G Tremblay
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada
| | - Mani Jain
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; Département de Biologie, Département de Biochimie, Microbiologie et Bio-informatique and Institut de Biologie Intégrative et des Systèmes, Université Laval, Québec, QC, Canada
| | - Sylvie Bourassa
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada
| | - Gerald D Gish
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex, Toronto, ON, Canada
| | - Jean-Philippe Gagné
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada
| | - Guy G Poirier
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Université Laval, Québec, QC, Canada
| | - Patrick Laprise
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Université Laval, Québec, QC, Canada
| | - Normand Voyer
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; Département de Chimie, Université Laval, Québec, QC, Canada
| | - Christian R Landry
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; Département de Biologie, Département de Biochimie, Microbiologie et Bio-informatique and Institut de Biologie Intégrative et des Systèmes, Université Laval, Québec, QC, Canada
| | - Nicolas Doucet
- PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; INRS-Institut Armand-Frappier, Université du Québec, Laval, QC, Canada
| | - Nicolas Bisson
- Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe Oncologie, Québec, QC, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC, Canada; PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada; Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Université Laval, Québec, QC, Canada.
| |
Collapse
|